Efficacy and safety of concurrent training in systemic sclerosis.
The optimal training model for patients with systemic sclerosis (SSc) is unknown. In this study, we aimed to investigate the effects of a 12-week combined resistance and aerobic training program (concurrent training) in SSc patients. Eleven patients with no evidence of pulmonary involvement were recruited for the exercise program. Lower and upper limb dynamic strengths (assessed by 1 repetition maximum [1RM] of a leg press and bench press, respectively), isometric strength (assessed by back pull and handgrip tests), balance and mobility (assessed by the timed up-and-go test), muscle function (assessed by the timed-stands test), Rodnan score, digital ulcers, Rayland's phenomenon, and blood markers of muscle inflammation (creatine kinase and aldolase) were assessed at baseline and after the 12-week program. Exercise training significantly enhanced the 1RM leg press (41%) and 1RM bench press (13%) values and back pull (24%) and handgrip strength (11%). Muscle function was also improved (15%), but balance and mobility were not significantly changed. The time-to-exhaustion was increased (46.5%, p = 0.0004), the heart rate at rest condition was significantly reduced, and the workload and time of exercise at ventilatory thresholds and peak of exercise were increased. However, maximal and submaximal &OV0312;o2 were unaltered (p > 0.05). The Rodnan score was unchanged, and muscle enzymes remained within normal levels. No change was observed in digital ulcers and Raynaud's phenomenon. This is the first study to demonstrate that a 12-week concurrent training program is safe and substantially improves muscle strength, function, and aerobic capacity in SSc patients.
Laboratory of Assessment and Conditioning in Rheumatology, School of Medicine, University of Sao Paulo, Sao Paulo, Brazil.
Ana L S
AL
Pinto
Natália C
NC
Oliveira
Bruno
B
Gualano
Romy B
RB
Christmann
Vitor S
VS
Painelli
Guilherme G
GG
Artioli
Danilo M L
DM
Prado
Fernanda R
FR
Lima
D000328:Adult; D015331:Cohort Studies; D015444:Exercise; D005081:Exercise Therapy / Q000379:methods; D017079:Exercise Tolerance / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D053580:Muscle Strength / Q000502:physiology*; D017060:Patient Satisfaction; D010807:Physical Endurance / Q000502:physiology*; D055070:Resistance Training; D018570:Risk Assessment; D017751:Safety Management; D012595:Scleroderma, Systemic / Q000175:diagnosis / Q000534:rehabilitation*; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome